Surgical resection of a solitary pancreatic metastasis from colorectal cancer: A new step to a cure?

Clinical Colorectal Cancer

Volumn 7, Issue 6, 2008, Pages 398-401

  Gravalos, Cristina ^a,c   García Sanchez, Lourdes ^a   Hernandez, Marta ^a   Holgado, Esther ^a   Alvarez, Natalia ^a   García Escobar, Ignacio ^a   Martínez, Joaquín ^b   Robles, Luis ^c  

^a Medical Oncology Department   (Spain)

^b Molecular Pathology Programme   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Hereditary cancer; Mismatch repair gene; MutS homologue; Neoadjuvant chemotherapy

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PAIN; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; COLON ADENOCARCINOMA; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE FREE INTERVAL; DUODENUM OBSTRUCTION; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FOLLOW UP; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL INFORMATION; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROENDOCRINE TUMOR; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE JAUNDICE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS METASTASIS; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; SURGICAL RISK; SYMPTOM; TUMOR VOLUME; WEIGHT REDUCTION;

EID: 58849099269     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2008.n.053     Document Type: Article

References (25)

1. Z'graggen K, Fernandez del Castillo C, Rattner DW, et al. Metastases to the pancreas and their surgical extirpation. Arch Surg 1988; 133:413-7.
2. Adsay NV, Andrea A, Basturk O, et al. Secondary tumours of the pancreas: an analysis of a surgical and autopsy data-base and review of the literature. Virchows Arch 2004; 444:527-35.
3. Washington K, McDonagh D. Secondary tumours of the gastrointestinal tract: surgical pathologic findings and comparison with autopsy survey. Mod Pathol 1995; 8:427-33.
4. Ronald CF, Herrden JA. Non pancreatic primary tumous with metastases to the pancreas. Surg Gynecol Obstet 1989; 168:345-7.
5. Sperti C, Pasquali C, Liessi G, et al. Pancreatic resection for metastatic tumours to the pancreas. J Surg Oncol 2003; 83:161-6.
6. Brady LW, O'Neill EA, Farber SH. Unusual sites of metastases to the pancreas. Semin Oncol 1977; 4:59-64.
7. Pereira-Lima JC, Coral GP, Bayer LR, et al. Metastasis from colon carcinoma in the dorsal pancreas of a patient with pancreas divisum: report of a case. Hepatogas- troenterology 2000: 47:554-5.
8. Kamangar F, Dores GM, Anderson WF. Patterns of care incidence, mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 26:2137-50.
9. Shimoda M, Kuboata K, Kita J, et al. Is a patient with metastatic pancreatic tumor from rectal cancer a candidate for resection? A case report. Hepatogastroenterology 2007; 54:1262-5.
10. Bougghene FP, Deslandes PM, Leblanche AF. US and CT imaging features of intrapancreatic metastases. J Comp Assist Tomogr 1994; 18:905-10.
11. Crippa S, Angelini C, Mussi C, et al. Surgical treatment of metastatic tumors to the pancreas: A single center experience and review of the literature. World J Surg 2006; 30:1536-42.
12. Hughes JH, Jensen CS, Donnelly AD, et al. The role of fine-needle aspiration cytology in the evaluation of metastatic clear cell tumors. Cancer 1999; 87:380-9.
13. Lynch HT, Voorhees GJ, Lanspa SG, et al. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer 1985; 52:271-3.
14. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96:261-8.
15. Banville N, Geraghty R, Fox E, et al. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Human Pathology 2006; 37:1498-502.
16. Arnold CN, Goel A, Boland CR. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int J Cancer 2003; 106:66-73.
17. Jover R, Zapater P, Castels A, et al. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006; 55:848-55.
18. Plasencia C, Taron M, Abad A, et al. Synergism of oxaliplatin (OXA) with either 5-Fluoruracil (5FU) or Topoisomerase I inhibitor in sensitive and 5FU-resistant colorectal cell lines is independent of DNA-mismatch repair and p53 status. Proc Am Soc Clin Oncol 2000; 19:204a (Abstract 793).
19. Magrini R, Bhonde MR, Hanski ML, et al. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status. Int J Cancer 2002; 101:23-31.
20. Hiotis S, Klimstra DS, Conlon KC. Results after pancreatic resection for metastatic lesions. Ann Surg Oncol 2002; 9:675-9.
21. Showalter SL, Hager E, Yeo CJ. Metastatic disease to the pancreas and spleen. Semin Oncol 2008; 35:160-71.
22. Medina-Franco H, Halpern NB, Aldret JS. Pancreatico-duodenectomy for metastatic tumours to the periampullary region. J Gastrointest Surg 1999; 3:119-22.
23. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreatico- duodenectomies in the 1990s. Pathology, complications and outcome. Ann Surg 1997; 226:248-60.
24. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25:4575-80.
25. Dahabre J, Vasilaki M, Stathopoulos GP, et al. Surgical management in lung metastases from colorectal cancer. Anticancer Res 2007; 27:4387-90.